Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
about
GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human diseaseHSPA5/Dna K may be a useful target for human disease therapies.PDE5 inhibitors as therapeutics for heart disease, diabetes and cancerOSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer TherapiesGRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases.Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistanceMulti-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone functionThe afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling.ABCG1 maintains high-grade glioma survival in vitro and in vivo.Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo.Phase I study of pemetrexed with sorafenib in advanced solid tumors.Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome.AR-12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication.[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling.AR-12 Inhibits Chaperone Proteins Preventing Virus Replication and the Accumulation of Toxic Misfolded Proteins.Effect of glycosides of Cistanche on the expression of mitochondrial precursor protein and keratin type II cytoskeletal 6A in a rat model of vascular dementia.Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.The celecoxib derivatives AR-12 and AR-14 induce autophagy and clear prion-infected cells from prions.Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies.Beyond Alkylating Agents for Gliomas: Quo Vadimus?Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.
P2860
Q28254667-C3B126B8-47A8-40F5-8257-FE67D297F97AQ35110761-8AED83FA-6BB8-401C-91EA-B1A7B5C28A18Q35827798-A05E5C63-0617-46AB-B7B2-7B24B473D819Q36808317-E98A17A5-08E9-4AED-8A7F-B20EC0B85D07Q36830763-72407D07-57C5-4BE0-B308-92E92129A419Q36839023-A7A059E8-0276-42B9-B5E8-9A302A782243Q37022352-D269B826-21E2-418F-AB0A-C741F8720C98Q37190128-9E41DABD-8D72-4E7F-9853-83A1AD6CE83BQ37269034-923B6913-EE42-4514-9972-007DCED4BE9AQ37457895-AB5449F9-379C-4618-93D2-4BCBF52DA456Q37520649-ADAED215-651B-4335-9F08-7F2A697FEA74Q37706584-1E0703CC-AB02-478E-8297-52B732FD14F6Q38770459-86F99F3B-3036-4C67-979B-A680DED37B37Q39888747-117799C4-449B-432D-A8B2-EB7963E86ADFQ40412357-8B3A032F-5B39-4D3E-AE40-6A89765820D0Q41429905-23667478-761C-4C38-9882-D2716A42235DQ41820623-D6AD667C-558A-4E33-A50F-AD28CD2560EAQ46240779-8FB04095-3B34-489D-BC06-04900BA1FF04Q47738152-6CFA8BF3-BCF6-434C-BC3E-933873E480F7Q49189846-B0A29FD0-FC93-4228-92C3-27CEAA382DD9Q55247585-FAC96838-A722-486A-8974-D940DBD9CD08
P2860
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@ast
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@en
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@nl
type
label
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@ast
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@en
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@nl
prefLabel
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@ast
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@en
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@nl
P2093
P2860
P1476
Regulation of OSU-03012 toxicity by ER stress proteins and ER stress-inducing drugs.
@en
P2093
Andrew Poklepovic
Jane L Roberts
Laurence Booth
Nichola Cruickshanks
Steven Grant
P2860
P304
P356
10.1158/1535-7163.MCT-14-0172
P50
P577
2014-08-07T00:00:00Z